CASP3 and breast carcinoma: Caspase-9 activities followed the similar pattern as caspase-3 and increased 5–6 folds at 16 h only in CHX-treated MCF-10A and HMLE cells, while no significant increased activity was detected in breast cancer cells (Figure 1D).